Peer-reviewedLicence not statedJournal of Managed Care & Specialty Pharmacy
Economic burden of immune-mediated and psychiatric comorbidities in patients with newly diagnosed vitiligo
- 1Department of Dermatology, Indiana University School of Medicine, Indianapolis
- 2AbbVie, Inc, North Chicago, IL
- 3Department of Dermatology, Keck School of Medicine at the University of Southern California, Los Angeles
Related
- Neuroinflammation as a shared mechanism linking epilepsy and psychiatric comorbidities
- Immune-mediated comorbidities in multiple sclerosis: a scoping review
- Pathogenic autoantibodies targeting DNA repair proteins are shared by cancer patients and healthy children later diagnosed with cancer
- Perceptions, knowledge, and attitudes toward genetics among psychiatric patients and their relatives: A systematic review and a meta-analysis
- Awareness of hereditary breast cancer and readiness for genetic testing among newly diagnosed patients with breast cancer in Nigeria: a multicentre study.
BibTeX
@article{rosmarin2026economic,
title = {{Economic burden of immune-mediated and psychiatric comorbidities in patients with newly diagnosed vitiligo}},
author = {David Rosmarin and Ahmed M. Soliman and Kent A. Hanson and Bang Truong and Sylvester Uwumarogie and Nguyen Le and Nada Elbuluk},
journal = {Journal of Managed Care \& Specialty Pharmacy},
year = {2026},
month = nov,
doi = {10.18553/jmcp.2026.26157},
url = {https://doi.org/10.18553/jmcp.2026.26157},
}
RIS
TY - JOUR
TI - Economic burden of immune-mediated and psychiatric comorbidities in patients with newly diagnosed vitiligo
AU - David Rosmarin
AU - Ahmed M. Soliman
AU - Kent A. Hanson
AU - Bang Truong
AU - Sylvester Uwumarogie
AU - Nguyen Le
AU - Nada Elbuluk
PY - 2026
DA - 2026/11/01
JO - Journal of Managed Care & Specialty Pharmacy
DO - 10.18553/jmcp.2026.26157
UR - https://doi.org/10.18553/jmcp.2026.26157
SN - 2376-0540
SN - 2376-1032
ER -